As well as highlighting mutation of genes with established roles in MM, we identified a number of frequently acquired de novo coding mutations (e.g., FAM46C, TRAF2, NF1, and XBP1), de novo translocation (MAP3K14) and pre-existing mutations (e.g., TET2). The gene discussed is TET2; the disease is Miyoshi myopathy.